Rongshou Zheng

ORCID: 0000-0003-4295-3398
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Cancer Incidence and Screening
  • Esophageal Cancer Research and Treatment
  • Colorectal Cancer Screening and Detection
  • Cancer Risks and Factors
  • Gastric Cancer Management and Outcomes
  • Cervical Cancer and HPV Research
  • Multiple and Secondary Primary Cancers
  • Esophageal and GI Pathology
  • Cancer-related molecular mechanisms research
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Global Public Health Policies and Epidemiology
  • Head and Neck Cancer Studies
  • Air Quality and Health Impacts
  • Acute Lymphoblastic Leukemia research
  • Liver Disease Diagnosis and Treatment
  • Epigenetics and DNA Methylation
  • Lung Cancer Treatments and Mutations
  • Childhood Cancer Survivors' Quality of Life
  • Global Health Care Issues
  • Helicobacter pylori-related gastroenterology studies
  • Glutathione Transferases and Polymorphisms
  • Economic and Financial Impacts of Cancer
  • Energy and Environment Impacts
  • Bladder and Urothelial Cancer Treatments
  • Thyroid Cancer Diagnosis and Treatment

Chinese Academy of Medical Sciences & Peking Union Medical College
2016-2025

Academy of Medical Sciences
2012-2022

Cancer Hospital of Chinese Academy of Medical Sciences
2012-2022

National Cancer Registry
2012-2021

Fourth Hospital of Hebei Medical University
2020

Hospital of Hebei Province
2020

Hebei Medical University
2020

National Clinical Research
2018-2019

Peking Union Medical College Hospital
2019

Tumor Hospital of Xinjiang Medical University
2018

With increasing incidence and mortality, cancer is the leading cause of death in China a major public health problem. Because China's massive population (1.37 billion), previous national mortality estimates have been limited to small samples using data from 1990s or based on specific year. high‐quality an additional number population‐based registries now available through National Central Cancer Registry China, authors analyzed 72 local, (2009‐2011), representing 6.5% population, estimate...

10.3322/caac.21338 article EN CA A Cancer Journal for Clinicians 2016-01-25

From 2003 to 2005, standardised 5-year cancer survival in China was much lower than developed countries and varied substantially by geographical area. Monitoring population-level is crucial the understanding of overall effectiveness care. We therefore aimed investigate statistics for people with between 2015.

10.1016/s2214-109x(18)30127-x article EN cc-by The Lancet Global Health 2018-04-10

National Cancer Center (NCC) of China annually reports the nationwide statistics for cancer incidence and mortality using population-based registry data from all available registries in China.

10.1016/j.jncc.2022.02.002 article EN cc-by Journal of the National Cancer Center 2022-02-27

National Central Cancer Registry of China (NCCRC) updated nationwide cancer statistics using population-based registry data in 2014 collected from all available registries.In 2017, 449 registries submitted 2014, among which 339 registries' met the criteria quality control and were included analysis. These covered 288,243,347 population, accounting for about 21.07% national population 2014. Numbers new cases deaths estimated calculated incidence mortality rates corresponding stratified by...

10.21147/j.issn.1000-9604.2018.01.01 article EN Chinese Journal of Cancer Research 2018-01-01

Abstract Background Breast cancer is the most commonly diagnosed and leading cause of death among women worldwide but has patterns trends which vary in different countries. This study aimed to evaluate global breast incidence mortality analyze its temporal for prevention control. Methods data 2020 were obtained from GLOBOCAN online database. Continued Cancer Incidence Five Continents Time Trends, International Agency Research on China National Central Registry used time 2000 2015 through...

10.1002/cac2.12207 article EN cc-by-nc-nd Cancer Communications 2021-08-16

The National Cancer Center (NCC) of China regularly reports the nationwide statistics on cancer incidence and mortality in China. International Agency for Research (IARC) calculates publishes burden countries around world every two years. To ensure consistency between actual surveillance data published by IARC, NCC has received approval from Health Commission IARC to simultaneously release GLOBOCAN 2022. There were a total 700 registries reporting high-quality across 2018, which 106 with...

10.1016/j.jncc.2024.01.006 article EN cc-by-nc-nd Journal of the National Cancer Center 2024-02-02

Objective: Data from local cancer registries were pooled to estimate incidence and mortality in China, 2015. Methods: submitted 501 checked & evaluated according the criteria of data quality control, 368 registries' qualified for final analysis. stratified by area (urban/rural), sex, age group sites, combined with national population Chinese census 2000 Segi's used age-standardized. Results: Total covered 309 553 499 (148 804 626 urban 160 748 873 rural areas). The percentage morphologically...

10.3760/cma.j.issn.0253-3766.2019.01.005 article EN PubMed 2019-01-23

Limited population‐based cancer registry data available in China until now has hampered efforts to inform control policy. Following extensive improve the systematic surveillance this country, we report on largest pooled analysis of survival date. Of 21 registries, from 17 registries ( n = 138,852 records) were included final analysis. Cases diagnosed 2003–2005 and followed end 2010. Age‐standardized relative was calculated using region‐specific life tables for all cancers combined 26...

10.1002/ijc.29227 article EN International Journal of Cancer 2014-09-20

Lung cancer is the most common and leading cause of death in China. Along with socioeconomic development, environmental problems have intensified burden lung continues to increase.In this study, national registry data was used for evaluating incidence, mortality, time trend, prediction.In China 2010, 605 900 patients were diagnosed 486 600 died cancer. Throughout last three decades, mortality has dramatically increased, as shown surveys. From 2000 age specific incidence increased groups. It...

10.1111/1759-7714.12169 article EN cc-by-nc Thoracic Cancer 2014-08-29

Population-based cancer registration data in 2010 were collected, evaluated and analyzed by the National Central Cancer Registry (NCCR) of China. incident new cases deaths estimated.

10.3978/j.issn.1000-9604.2014.01.08 article EN PubMed 2014-02-01

The National Central Cancer Registry (NCCR) collected population-based cancer registration data in 2012 from local registries and estimated the incidence mortality China. In middle of 2015, 261 submitted reports on new cases deaths occurred 2012. Qualified 193 were used for analysis after evaluation. Crude rates, number cases, age-standardized rates stratified by area (urban/rural), sex, age group, type calculated according to national population covered 198,060,406 qualified (74 urban 119...

10.1186/s40880-016-0137-8 article EN cc-by Chinese Journal of Cancer 2016-08-02

Nasopharyngeal carcinoma (NPC) is common in South China. Although regional epidemiological data on NPC China available, national have been unavailable up to now. The goal of this study was analyze the incidence and mortality some domestic cancer registries, estimate these rates 2010, provide scientific information that can be harnessed for control prevention. To accomplish goal, 2010 were collected from 145 Chinese registries which included 2013 National Cancer Registry Annual Report. Such...

10.5732/cjc.014.10086 article EN cc-by 2014-08-01

National Cancer Center (NCC) updated nationwide cancer statistics using population-based registry data in 2015.

10.1016/j.jncc.2020.12.001 article EN cc-by-nc-nd Journal of the National Cancer Center 2020-12-31

The National Central Cancer Registry (NCCR) is a governmental organization for cancer surveillance affiliated to the Bureau of Disease Control, Ministry Health, in China. It annually collects registration data from local registries and then analyzes publishes results provide useful information making anti-cancer policy, program evaluation, etiology research. At end 2012, NCCR reported statistics 2009.By mid 104 population-based incidence mortality data, including demographic information,...

10.1111/1759-7714.12025 article EN other-oa Thoracic Cancer 2012-12-28

Abstract Objective: Liver cancer is one of the most common cancers and major cause deaths in China, which accounts for over 50% new cases worldwide. The systematic liver statistics including projection through 2030 could provide valuable information prevention control strategies experience other countries. Methods: burden China 2014 was estimated using 339 registries' data selected from Chinese National Cancer Center (NCC). Incident 22 registries were applied temporal trends 2000 to 2014....

10.21147/j.issn.1000-9604.2018.06.01 article EN Chinese Journal of Cancer Research 2018-01-01

Annual cancer incidence and mortality in 2008 were provided by National Central Cancer Registry China, which data collected from population-based registries 2011. There 56 submitted their 2008. After checking evaluating the quality, total 41 registries' accepted pooled for analysis. Incidence rates area (urban or rural areas) assessed, as well age- sex-specific rates, age-standardized proportions cumulative rate. The coverage population of was 66,138,784 with 52,158,495 urban areas...

10.1007/s11670-012-0171-2 article EN Chinese Journal of Cancer Research 2012-03-01

We estimated the incidence and mortality of nasopharyngeal carcinoma (NPC) in China 2010 according to data 145 domestic population-based cancer registries 2014, no such reports since then. Hence, further better understand its epidemiology provide more precise scientific information for control prevention China, we analyzed NPC 255 registries, national rates 2013 again. 2013, accepted by 2016 National Cancer Registry Annual Report, were collected collated, indices as numbers new cases deaths,...

10.1186/s40880-017-0257-9 article EN cc-by Chinese Journal of Cancer 2017-11-09

The National Central Cancer Registry (NCCR) collected cancer registration data in 2009 from local registries 2012, and analyzed to describe incidence mortality China.On basis of the criteria quality NCCR, submitted 104 were checked evaluated. There 72 registries' qualified accepted for registry annual report 2012. Descriptive analysis included stratified by area (urban/rural), sex, age group site. top 10 common cancers different groups, proportion cumulative rates also calculated. Chinese...

10.3978/j.issn.1000-9604.2012.12.04 article EN PubMed 2013-02-01

To estimate the cancer incidences and mortalities in China 2010.On basis of evaluation procedures data quality criteria described National Central Cancer Registry (NCCR), from 219 registries were evaluated. Data 145 identified as qualified then accepted for 2010 registry report. The major cancers overall incidence mortality stratified by residency (urban or rural), areas (eastern, middle, western), gender, age. cases deaths estimated based on age-specific rate national population 2010....

10.3978/j.issn.2305-5839.2014.04.05 article EN PubMed 2014-07-01

BackgroundUnderstanding disparities in the burden of cancer attributable to different risk factors is crucial inform and improve prevention control. In this report, we estimate site-specific population-attributable fractions (PAFs) for 23 potentially modifiable across all provinces China.MethodsIn comparative assessment study, used 2014 mortality data adults from 978 county-level surveillance points 31 mainland China. Risk-factor prevalence estimates were obtained representative surveys. We...

10.1016/s2214-109x(18)30488-1 article EN cc-by-nc-nd The Lancet Global Health 2019-01-27
Coming Soon ...